Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI

Published:2016-12 Issue:12 Volume:107 Page:1851-1857
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ye Kaishan¹,Wang Shuanke¹,Wang Jing¹,Han Hua¹,Ma Bing¹,Yang Yong¹

Affiliation:

1. Department of Orthopaedics Lanzhou University Second Hospital Lanzhou Gansu China

Funder

Science and Technology Department of Gansu Province Innovative Research Group Program

The Science and Technology Department of Gansu Province Natural Science Foundation Program

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13088

Reference24 articles.

1. HMGB1 Promotes Drug Resistance in Osteosarcoma

2. Osteosarcoma (Osteogenic sarcoma)

3. Zebularine: A Novel DNA Methylation Inhibitor that Forms a Covalent Complex with DNA Methyltransferases

4. DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer

5. Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing a Blood-Based Test in Breast Cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting DNA Methylation Machinery in Pediatric Solid Tumors;Cells;2024-07-18

2. Trends in primary malignant bone cancer incidence and mortality in the United States, 2000–2017: A population-based study;Journal of Bone Oncology;2024-06

3. Epigenetic Changes Induced by Infectious Agents in Cancer;Pathogens Associated with the Development of Cancer in Humans;2024

4. Nano‐Regulator Inhibits Tumor Immune Escape via the “Two‐Way Regulation” Epigenetic Therapy Strategy;Advanced Science;2023-12-18

5. Insights into DNMT1 and programmed cell death in diseases;Biomedicine & Pharmacotherapy;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3